108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
一种融合专科护士主导护理与智能平台的新型随访模式对腹膜透析患者的影响
Authors Wang J , Chang J, Yu Q, Liu J, Zheng Z , Bao J
Received 3 June 2025
Accepted for publication 27 September 2025
Published 6 October 2025 Volume 2025:18 Pages 303—311
DOI https://doi.org/10.2147/IJNRD.S544378
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Pravin Singhal
Ji Wang,1– 3,* Jian Chang,2,* Qing Yu,1,3 Jun Liu,1,3 Zhihuang Zheng,1 Jinfang Bao1,3
1Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Nursing Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 3Peritoneal Dialysis Center of Shanghai General Hospital (South), Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jinfang Bao, Department of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650, Xinsongjiang Road, Shanghai, 201600, People’s Republic of China, Tel +86 021 63240090, Email bamboobao@163.com Zhihuang Zheng, Department of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650, Xinsongjiang Road, Shanghai, 201600, People’s Republic of China, Tel +86 021 63248556, Email zhihuang.zheng@shgh.cn
Purpose: To evaluate the effect of a novel follow-up mode integrating specialist nurse-led care and an intelligent platform on fluid volume management in patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD).
Patients and Methods: A pre- and post-observational clinical cohort of 80 PD patients (Shanghai General Hospital South, Mar 2020–Mar 2021) evaluated the 12-month impact of the novel mode on fluid volume overload (FVL), cardiac function, laboratory indicators (including biochemical parameters and electrolytes), and clinically relevant complications (peritonitis, exit-site/tunnel infection and catheter displacement).
Results: After 12 months of follow-up using the novel mode, significant improvements were observed compared to the traditional follow-up approach. Specifically, levels of B-type natriuretic peptide (BNP) (144.12± 14.21 vs 631.01± 104.21 pg/mL, P < 0.001), systolic blood pressure (SBP) (136.99± 12.04 vs 145.34± 15.22 mmHg, P < 0.001), and diastolic blood pressure (DBP) (79.03± 6.35 vs 84.87± 8.17 mmHg, P < 0.01) were significantly lower in patients managed with the novel mode. Additionally, blood calcium (2.24± 0.52 vs 2.18± 0.02 pg/mL, P < 0.05), phosphorus (1.96± 0.07 vs 1.80± 0.06 mmol/L, P < 0.01), parathyroid hormone (PTH) (409.28± 43.49 vs 250.84± 23.26 pg/mL, P < 0.001), and albumin (38.89± 0.60 vs 36.25± 0.51 pg/mL, P < 0.001) levels were higher following implementation of the novel mode. FVL and cardiac function also showed significant improvement over the 12-months follow-up period. Notably, compared with the preceding 12-month control period, the platform-based follow-up reduced clinically relevant infectious complications from 10.3% to 3.8% (McNemar mid-p = 0.077).
Conclusion: The novel follow-up mode effectively reduced fluid volume overload and improved cardiac function, offering clinical benefits for PD patients.
Keywords: end-stage renal disease, peritoneal dialysis, novel follow-up mode, nurse-led care, intelligent platform, fluid volume overload
1Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 2Nursing Department, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China; 3Peritoneal Dialysis Center of Shanghai General Hospital (South), Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jinfang Bao, Department of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650, Xinsongjiang Road, Shanghai, 201600, People’s Republic of China, Tel +86 021 63240090, Email bamboobao@163.com Zhihuang Zheng, Department of Nephrology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, No. 650, Xinsongjiang Road, Shanghai, 201600, People’s Republic of China, Tel +86 021 63248556, Email zhihuang.zheng@shgh.cn
Purpose: To evaluate the effect of a novel follow-up mode integrating specialist nurse-led care and an intelligent platform on fluid volume management in patients with end-stage renal disease (ESRD) undergoing peritoneal dialysis (PD).
Patients and Methods: A pre- and post-observational clinical cohort of 80 PD patients (Shanghai General Hospital South, Mar 2020–Mar 2021) evaluated the 12-month impact of the novel mode on fluid volume overload (FVL), cardiac function, laboratory indicators (including biochemical parameters and electrolytes), and clinically relevant complications (peritonitis, exit-site/tunnel infection and catheter displacement).
Results: After 12 months of follow-up using the novel mode, significant improvements were observed compared to the traditional follow-up approach. Specifically, levels of B-type natriuretic peptide (BNP) (144.12± 14.21 vs 631.01± 104.21 pg/mL, P < 0.001), systolic blood pressure (SBP) (136.99± 12.04 vs 145.34± 15.22 mmHg, P < 0.001), and diastolic blood pressure (DBP) (79.03± 6.35 vs 84.87± 8.17 mmHg, P < 0.01) were significantly lower in patients managed with the novel mode. Additionally, blood calcium (2.24± 0.52 vs 2.18± 0.02 pg/mL, P < 0.05), phosphorus (1.96± 0.07 vs 1.80± 0.06 mmol/L, P < 0.01), parathyroid hormone (PTH) (409.28± 43.49 vs 250.84± 23.26 pg/mL, P < 0.001), and albumin (38.89± 0.60 vs 36.25± 0.51 pg/mL, P < 0.001) levels were higher following implementation of the novel mode. FVL and cardiac function also showed significant improvement over the 12-months follow-up period. Notably, compared with the preceding 12-month control period, the platform-based follow-up reduced clinically relevant infectious complications from 10.3% to 3.8% (McNemar mid-p = 0.077).
Conclusion: The novel follow-up mode effectively reduced fluid volume overload and improved cardiac function, offering clinical benefits for PD patients.
Keywords: end-stage renal disease, peritoneal dialysis, novel follow-up mode, nurse-led care, intelligent platform, fluid volume overload